glp-1 elevated liver enzymes Does Affect Enzymes? Effects on Liver Health Glucagon-like peptide (GLP)-1 and GLP-2

Clinical trials have shown that dual agonists significantly reduce hepatic fat and NASH progression

The appetite-inhibiting effect of GLP-1RA may depend on the 43% smaller decrease in free leptin levels, predominantly mediated by a 59% smaller increase in soluble leptin receptor, and higher PYY 336 meal responses may also contribute

Compliance and Risk: With GLP-1s, compliance isnt just box-checking

The future of obesity treatment is brighter than ever, and these medications are at the forefront

Lotte Bjerre Knudsen, the legendary Chief Scientific Advisor at Novo Nordisk and the driving force behind the development of semaglutide (recently recognized with the 2025 Breakthrough Prize), took the stage